Actinium Pharmaceuticals Inc. (Delaware) (ATNM) Dipped -5.14% or -0.02 To Price $0.43 On Monday


Actinium Pharmaceuticals Inc. (Delaware) (ATNM) dipped -5.14% or -0.02 to $0.43. It is near 403636 shares traded, which is 36.91% compare to the average total volume 1.09 million. The market cap of ATNM is $50.16 million. The year to date change is -34.34%. The 52 week price range is from $0.33 to $0.87. Price of ATNM have changed -21.27% during last week. It have changed -16.70% over last month, -29.71% over last 3 months, -0.65% over last 6 months and -33.77% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ATNM is 0.63. It is 46.51% above current price. The 200-day Moving Averages for ATNM is 0.55. It is 27.91% above current price. The 52-week High is 0.87. It is 102.33% from the current price. The 52-week Low is 0.33. It is -23.26% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ATNM is 2.81 on 2018-11-15. Short % to float is 2.58%. There are some statistics of ATNM. It is has market cap $50.16 million. The share outstanding is 115.70 million. The average volume is 1.09 million. The percent of top 15 Institution holding is 11.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ATNM is -151.13%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ATNM is -120.23%.


Tags:

Share this post